Bone Marrow TransplantationBone MarrowTransplantation, HomologousHematologic NeoplasmsBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousHematopoietic Stem Cell TransplantationLeukemiaWhole-Body IrradiationTransplantation ConditioningBone and BonesAnemia, AplasticTransplantation ChimeraTissue DonorsGraft SurvivalLiver TransplantationBusulfanHistocompatibility TestingHistocompatibilityBone Marrow PurgingCyclophosphamideHematopoietic Stem CellsLeukemia, Myeloid, AcuteTreatment OutcomeRecurrenceTransplantation, IsogeneicLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSelenomethionineCombined Modality TherapyHematopoiesisPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, Non-HodgkinKidney TransplantationLeukemia, MyeloidMyelodysplastic SyndromesImmunosuppressive AgentsRemission InductionMice, Inbred C57BLTime FactorsRetrospective StudiesHepatic Veno-Occlusive DiseaseLymphomaAcute DiseaseRadiation ChimeraGraft RejectionStem Cell TransplantationBone Marrow ExaminationSurvival AnalysisTransplantation ImmunologyLymphocyte DepletionHematologic DiseasesImmunosuppressionLeukocyte TransfusionBone RemodelingHLA AntigensMultiple MyelomaT-LymphocytesBone Marrow NeoplasmsGraft vs Host ReactionLymphocyte TransfusionChimeraHeart TransplantationSurvival RateGraft vs Tumor EffectCord Blood Stem Cell TransplantationSevere Combined ImmunodeficiencyAntineoplastic Combined Chemotherapy ProtocolsGraft vs Leukemia EffectCyclosporineActuarial AnalysisFollow-Up StudiesColony-Forming Units AssayLung TransplantationOpportunistic InfectionsDisease-Free SurvivalNuclear FamilyImmunocompromised HostBone DensityHodgkin DiseasePrognosisLeukocyte CountCytomegalovirus InfectionsCell DifferentiationCytarabineFlow CytometryGranulocyte Colony-Stimulating FactorPeripheral Blood Stem Cell TransplantationOrgan TransplantationMelphalanNeoplasmsCarmustinePancytopeniaAntilymphocyte SerumFatal OutcomeMice, Inbred BALB CNeutropeniaEtoposideChimerismMycoses